How big is the Korea Pharmaceutical Market?

The Korea Pharmaceutical Market size is expected to reach USD 23.19 billion in 2025 and grow at a CAGR of 2.40% to reach USD 26.11 billion by 2030. Read More

What is the current Korea Pharmaceutical Market size?

In 2025, the Korea Pharmaceutical Market size is expected to reach USD 23.19 billion. Read More

Who are the key players in Korea Pharmaceutical Market?

AbbVie Inc., AstraZeneca plc, Bayer AG, SAMSUNG PHARM. Co., LTD. and GlaxoSmithKline plc are the major companies operating in the Korea Pharmaceutical Market. Read More

What years does this Korea Pharmaceutical Market cover, and what was the market size in 2024?

In 2024, the Korea Pharmaceutical Market size was estimated at USD 22.63 billion. The report covers the Korea Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Korea Pharmaceutical Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030. Read More

Korea Pharmaceutical Market Share

Statistics for the 2023 & 2024 Korea Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Korea Pharmaceutical share report includes a market forecast to 2030 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Korea Pharmaceutical Industry Overview

The Korean pharmaceutical market is highly competitive and consists of several major players. A few major players dominate the market in terms of market share. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. The key companies dominating the market are AbbVie Inc., AstraZeneca PLC, Bayer AG, and SAMSUNG PHARM. Co. LTD, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co. Inc., and Sanofi SA.